al., unpublished data). This gives reassurance that the combined detection of lytA and a cspA gene 1 7 0 sequence common to serotypes 6A/B indicates the presence of the experimental pneumococcal 1 7 1 6B used in this study. We therefore report the results of our lytA/cpsA multiplex qPCR as the 1 7 2 accurate numbers for molecular detection of experimental colonisation in these study participants. 1 7 3
The number of volunteers that became colonised after experimental pneumococcal inoculation by 1 7 4 molecular methods was higher than the number previously reported by classical culture [8] . This 1 7 5 increase in number is more pronounced in the PCV arm (23 vs 4 volunteers) than in the control 1 7 6 arm (31 vs 23 volunteers), which translates into increased risk ratios, and therefore a decrease in 1 7 7 the calculated protective efficacy of PCV against pneumococcal colonisation from 83% to 29%. 1 7 8
Molecular methods, such as qPCR can detect DNA from dead bacteria. However, it is unlikely that 1 7 9 this phenomenon had a major contribution to our findings. If this method were detecting remains of 1 8 0 the pneumococcal inoculum administered on Day 0, we would expect to see higher colonisation 1 8 1 rates at D2 than D7. However, the colonisation rates on both days are comparable. does not greatly alter the mean colonisation density. However, in the control arm, the additional 1 8 7 low-density colonised volunteers have a larger effect in reducing the mean colonisation density. It 1 8 8 has been suggested that colonisation density plays an underestimated but pivotal role in the 1 8 9 development of pneumococcal disease and in transmission dynamics [17] [18] [19] . Our results further 1 9 0 support the hypothesis that colonisation density is a determining factor for the clinical outcome and 1 9 1 spread of S. pneumoniae and should be accounted for in the design of vaccine efficacy as well as 1 9 2 colonisation surveillance studies. Using molecular methods, we have shown that PCV conferred 29% protection against 1 9 5 experimental colonisation acquisition. This may indicate that the main protective mechanism of this 1 9 6 vaccine is mediated by reduction of colonisation density, leading to a decreased risk of disease to 1 9 7 vaccinated individuals as well as transmission resulting in the observed herd effects in vaccinated 1 9 8 populations. 
